RESUMO
The present study aims to estimate the dynamic effects of moisture levels and inoculants on the fermentation quality and in vitro degradability of Stylosanthes silage. In this experiment, Stylosanthes was ensiled with (1) no additive (control), (2) Lactobacillus plantarum (LP), (3) Lactobacillus plantarum carrying heterologous genes encoding multifunctional glycoside hydrolases (xg), or (4) LP + xg and was wilted until different moisture levels (60% and 72%) were attained. The ensiled bags were unpacked after different storage periods to determine the chemical composition and fermentation quality of the Stylosanthes silage. Moreover, the in vitro degradability was also determined 45 days after the ensiling process. The results show that the silage prepared with freshly mowed Stylosanthes also had a lower pH and NH3- N content. Adding transgenic engineered lactic acid bacteria xg not only decreased the NDF and ADF content of the silage, but also improved the in vitro digestibility significantly. We concluded that the addition of xg to Stylosanthes silage can improve its quality and increase in vitro digestibility and gas production. The results provide technical support and a theoretical basis for the utilization of warm-season forage silage.
RESUMO
Alzheimer's disease (AD) is a progressive neurodegeneration characterized by neuron death ending in memory and cognitive decline. A major concern in AD research is the identification of new therapeutics that could prevent or delay the onset of the disorder, with current treatments being effective only in reducing symptoms. In this perspective, the use of engineered probiotics as therapeutic tools for the delivery of molecules to eukaryotic cells is finding application in several disorders. This work introduces a new strategy for AD treatment based on the use of a Lactobacilluslactis strain carrying one plasmid (pExu) that contains a eukaryotic expression cassette encoding the human p62 protein. 3xTg-AD mice orally administered with these bacteria for two months showed an increased expression of endogenous p62 in the brain, with a protein delivery mechanism involving both lymphatic vessels and neural terminations, and positive effects on the major AD hallmarks. Mice showed ameliorated memory, modulation of the ubiquitin-proteasome system and autophagy, reduced levels of amyloid peptides, and diminished neuronal oxidative and inflammatory processes. Globally, we demonstrate that these extremely safe, non-pathogenic and non-invasive bacteria used as delivery vehicles for the p62 protein represent an innovative and realistic therapeutic approach in AD.